Recursion Pharmaceuticals, Inc. RXRX Occupancy and Related Charges
Occupancy and Related Charges at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s occupancy and related charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s occupancy and related charges?
- Recursion Pharmaceuticals, Inc. (RXRX) reported occupancy and related charges of $5.24M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s occupancy and related charges changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s occupancy and related charges decreased by 14.5% year-over-year, from $6.13M to $5.24M.
- What does occupancy and related charges mean?
- Reflects the cash outflow associated with operating lease obligations recognized within the operating section of the cash flow statement. It represents the recurring cost of utilizing leased facilities or equipment necessary for core business operations.